- 5 distinct GMP facilities in Atlantic Canada
- Headquarters and 4 complex chemistry facilities in Charlottetown, Prince Edward Island
- Biologics manufacturing in Windsor, Nova Scotia
- +25,000 m² manufacturing facility space
- 118,000 L of chemical reactor space (20 L to 18,000 L)
- 64,000 L of fermentation bioreactor capacity (30 L to 17,000 L)
- Various development and GMP manufacturing areas providing different types of capabilities, including:
- Class 100,000 (ISO 8/ Grade D) and 10,000 (ISO 7/ Grade C) controlled suites
- Highly Potent API Band 3 and 4 containment suites
- Commercial synthetic API manufacturing
- Commercial biologic drug substance production
- Full biologics development and characterization
- Multi-Reactor System and scale down high throughput setup
- Continuous processing/flow chemistry equipment
- Analytical development and 24/7 quality control
- Multiple qualified GMP storage areas (-80°C to 2-8°C) for raw materials, cell lines, and drug substances
Facility |
 Synthetic Small Molecules |
 Fermented Small Molecules |
 Highly Potent APIs |
 Bioreagents |
 Biologics |
 Regulatory Inspection History |
|---|---|---|---|---|---|---|
| Research & Development
17 Hillstrom Ave., PE |
|
|
|
|
   |
|
| Headquarters
11 Aviation Ave., PE |
|
|
|
|
|
|
| New API Facility
11 Aviation Ave., PE |
|
|||||
| Large Scale Biomanufacturing Facility
24 Ivey Lane, NS |
|
*Expected 2022 |
||||
| Dedicated Facility
29 McCarville St., PE |
Dedicated Natural Extraction | |||||
